Moreover, IHC allows for biomarker analysis in a subcellular context, which is particularly relevant as it appears to be mainly the nuclear expression of RBM3 that carries prognostic significance in bladder cancer [13, 14]. This evidence concerns the gene RBM3 and urinary bladder carcinoma.